zoledronic acid has been researched along with Femur Neck Fractures in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, XY; Li, XP; Wu, XB; Yang, MH; Zhang, P; Zhu, SW | 1 |
| Gao, J; Guan, J; Li, X; Xia, X; Xu, X; Zhang, C; Zhang, J; Zhang, T; Zhao, Z; Zhu, K | 1 |
| Abraham, JR; Araujo, AB; Bouxsein, ML; Chiu, G; Dagincourt, N; Holick, MF; Suarez, EA; Yang, M; Zmuda, JM | 1 |
| Black, DM; Boonen, S; Colón-Emeric, CS; Eastell, R; Eriksen, EF; Haentjens, P; Lyles, KW; Magaziner, JS; Mesenbrink, P | 1 |
| Chen, JF; Chen, PQ; Chin, LS; Hwang, JS; Leung, PC; Tsai, KS; Yang, TS | 1 |
| Kouvaris, C; Mouzopoulos, D; Mouzopoulos, G; Stamatakos, M; Tzurbakis, M | 1 |
2 trial(s) available for zoledronic acid and Femur Neck Fractures
| Article | Year |
|---|---|
Racial/ethnic and socioeconomic differences in bone loss among men.
Topics: Aged; Aged, 80 and over; Body Mass Index; Bone Density; Bone Density Conservation Agents; Diphosphonates; Female; Femoral Neck Fractures; Follow-Up Studies; Humans; Imidazoles; Male; Middle Aged; Racial Groups; Zoledronic Acid | 2014 |
The effects of intravenous zoledronic acid in Chinese women with postmenopausal osteoporosis.
Topics: Aged; Aged, 80 and over; Asian People; Bone Density; Bone Density Conservation Agents; China; Demography; Diphosphonates; Female; Femoral Neck Fractures; Hip Fractures; Humans; Imidazoles; Incidence; Injections, Intravenous; Middle Aged; Osteoporosis, Postmenopausal; Zoledronic Acid | 2011 |
4 other study(ies) available for zoledronic acid and Femur Neck Fractures
| Article | Year |
|---|---|
All-cause mortality risk in older patients with femoral neck fracture.
Topics: Aged; Aged, 80 and over; Female; Femoral Fractures; Femoral Neck Fractures; Femur Neck; Hip Fractures; Humans; Male; Prospective Studies; Risk Factors; Zoledronic Acid | 2022 |
Therapeutic efficacy of zoledronic acid combined with calcitriol in elderly patients receiving total hip arthroplasty or hemiarthroplasty for osteoporotic femoral neck fracture.
Topics: Aged; Arthroplasty, Replacement, Hip; Bone Density; Bone Density Conservation Agents; Calcitriol; Diphosphonates; Femoral Neck Fractures; Hemiarthroplasty; Humans; Imidazoles; Prospective Studies; Zoledronic Acid | 2021 |
Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older.
Topics: Age Factors; Aged; Bone Density; Bone Density Conservation Agents; Diphosphonates; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Femoral Neck Fractures; Fractures, Spontaneous; Humans; Imidazoles; Infusions, Intravenous; Medication Adherence; Osteoporosis; Randomized Controlled Trials as Topic; Spinal Fractures; Zoledronic Acid | 2010 |
Spontaneous bilateral subcapital hip fracture due to multiple myeloma: an 18-month follow-up.
Topics: Adult; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Femoral Neck Fractures; Fracture Fixation, Internal; Fractures, Spontaneous; Humans; Imidazoles; Male; Multiple Myeloma; Radiography; Zoledronic Acid | 2007 |